Skip to content

A Study to Investigate the Use of Hydrogel Vehicle in Maintaining the Skin Barrier in Persons With Atopic Dermatitis

Transepidermal Water Loss (TEWL) and Corneometry With Hydrogel Vehicle in the Treatment of Atopic Dermatitis - A Randomized, Investigator-Blind Pilot Study

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01065714
Enrollment
20
Registered
2010-02-09
Start date
2010-02-28
Completion date
2010-11-30
Last updated
2013-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic Dermatitis

Keywords

Transepidermal water loss, Epidermal barrier, Skin hydration

Brief summary

While the repair of the epidermal barrier in atopic dermatitis is of major importance in the treatment of atopic dermatitis, most of the vehicles used may actually cause a worsening of an impaired epidermal barrier. Hydrogel vehicle is anecdotally known to be moisturizing and hydrating.This study will compare the use of Hydrogel vehicle and Eucerin Lotion in maintaining the epidermal barrier in subjects with atopic dermatitis.

Interventions

DRUGHydrogel vehicle

Each morning and evening, gently wash the target area with warm water and gently pat dry with soft towel. Once dry place a small amount of Hydrogel vehicle onto the tip of your finger. Place a dab of the Hydrogel vehicle on either the left or right side of the body as instructed. (Do not use Hydrogel vehicle and Eucerin lotion on the same side of the body.)

DRUGEucerin Lotion

Each morning and evening, gently wash the area with warm water and pat dry with a soft towel. Once dry, place a small amount of Eucerin lotion to the target area on either the left or right side of the body as instructed. (Do not use Eucerin and Hydrogel vehicle on the same side of the body.)

Sponsors

Bayer
CollaboratorINDUSTRY
Derm Research, PLLC
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
12 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Definitive diagnosis of atopic dermatitis as characterized by Hanifin and Rajka criteria: * 3 out of 4 major characteristics * At least 3 minor characteristics * Mild to moderate disease score of 2 or 3 by Investigator Global Assessment * Minimum 5% Body Surface Area at Baseline * Uniformly bilateral signs and symptoms of atopic dermatitis * Able to understand and comply with the requirements of the study and sign Informed Consent/HIPAA forms. Subjects under the legal age of consent must also have written informed consent of the parent or legal guardian.

Exclusion criteria

* Allergy or sensitivity to any component of the test articles. * Subjects who have not complied with the proper washout periods for prohibited medications. * Significant coagulation disorder or any medical condition that, in the opinion of the investigator, contraindicates the subject's participation in the study. * Recent alcohol or drug abuse is evident. * History of poor cooperation, non-compliance with medical treatment or unreliability * Participation in an investigational drug study within 30 days of the Baseline Visit.

Design outcomes

Primary

MeasureTime frameDescription
Percent Change of Trans Epidermal Water Loss (TEWL) With Use of Eucerin LotionDay 1 to Day 14The average of three sequential Tewameter 300 meter readings taken at a minimum of one minute intervals on targeted area of body half treated with Eucerin lotion
Percent Change of Trans Epidural Water Loss (TEWL) With the Use of Hydrogel VehicleDay 1 to Day 14The average of three sequential Tewameter 300 meter readings taken at a minimum of one minute intervals on target areas of body half treated with Hydrogel vehicle

Secondary

MeasureTime frameDescription
Percentage of Participants With an Increase in Skin Hydration Using Eucerin Lotion on Targeted Area on One Half of BodyBaseline to 14 daysFive timed readings ( 0, 15, 30, 45 and 60 minutes) were taken using the Corneometer 825 meter on subjects using Eucerin lotion on targeted area on one half of body
Percentage of Participants With an Increase in Skin Hydration Using Hydrogel Vehicle on Targeted Area of One Half of Body.Baseline to 14 daysFive timed readings at (0, 15, 30, 45 and 60 minutes) were taken, using the Corneometer 825 meter, on participants using Hydrogel vehicle

Countries

United States

Participant flow

Recruitment details

Recruitment from March 2010 through September 2010. Subjects enrolled from physician data base.

Participants by arm

ArmCount
Hydrogel Vehicle/Eucerin Lotion
Parallel designed study. Split body treatment
20
Total20

Baseline characteristics

CharacteristicHydrogel Vehicle/Eucerin Lotion
Age, Categorical
<=18 years
4 Participants
Age, Categorical
>=65 years
1 Participants
Age, Categorical
Between 18 and 65 years
15 Participants
Age Continuous35 years
STANDARD_DEVIATION 16
Region of Enrollment
United States
20 participants
Sex: Female, Male
Female
11 Participants
Sex: Female, Male
Male
9 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 20
serious
Total, serious adverse events
0 / 20

Outcome results

Primary

Percent Change of Trans Epidermal Water Loss (TEWL) With Use of Eucerin Lotion

The average of three sequential Tewameter 300 meter readings taken at a minimum of one minute intervals on targeted area of body half treated with Eucerin lotion

Time frame: Day 1 to Day 14

Population: per protocol

ArmMeasureValue (MEDIAN)Dispersion
Skin Barrier Function With Eucerin LotionPercent Change of Trans Epidermal Water Loss (TEWL) With Use of Eucerin Lotion21.4 percent changeFull Range 54.8
Primary

Percent Change of Trans Epidural Water Loss (TEWL) With the Use of Hydrogel Vehicle

The average of three sequential Tewameter 300 meter readings taken at a minimum of one minute intervals on target areas of body half treated with Hydrogel vehicle

Time frame: Day 1 to Day 14

Population: Per protocol

ArmMeasureValue (MEDIAN)Dispersion
Skin Barrier Function With Eucerin LotionPercent Change of Trans Epidural Water Loss (TEWL) With the Use of Hydrogel Vehicle4.2 percent changeFull Range 31.2
Secondary

Percentage of Participants With an Increase in Skin Hydration Using Eucerin Lotion on Targeted Area on One Half of Body

Five timed readings ( 0, 15, 30, 45 and 60 minutes) were taken using the Corneometer 825 meter on subjects using Eucerin lotion on targeted area on one half of body

Time frame: Baseline to 14 days

Population: per protocol

ArmMeasureValue (MEAN)Dispersion
Skin Barrier Function With Eucerin LotionPercentage of Participants With an Increase in Skin Hydration Using Eucerin Lotion on Targeted Area on One Half of Body33.5 Percentage of participantsStandard Deviation 72.2
Secondary

Percentage of Participants With an Increase in Skin Hydration Using Hydrogel Vehicle on Targeted Area of One Half of Body.

Five timed readings at (0, 15, 30, 45 and 60 minutes) were taken, using the Corneometer 825 meter, on participants using Hydrogel vehicle

Time frame: Baseline to 14 days

Population: per protocol

ArmMeasureValue (MEAN)Dispersion
Skin Barrier Function With Eucerin LotionPercentage of Participants With an Increase in Skin Hydration Using Hydrogel Vehicle on Targeted Area of One Half of Body.32.3 percentage of participantsStandard Deviation 51.5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026